·07/05/13 Characteristics of Cavotricuspid Isthmus–Dependent Atrial Flutter After Left Atrial Ablation of Atrial Fibrillation
·07/05/13 Localized Sources Maintaining Atrial Fibrillation Organized by Prior Ablation
·07/05/13 Mechanisms of Wave Fractionation at Boundaries of High-Frequency Excitation in the Posterior Left Atrium of the Isolated Sheep Heart During Atrial Fibrillation
·07/05/13 Artificial Baroreflex
·07/05/13 Patients With Acute Coronary Syndrome Show Oligoclonal T-Cell Recruitment Within Unstable Plaque
·07/05/13 Dyslipidemia Prevalence, Treatment, and Control in the Multi-Ethnic Study of Atherosclerosis (MESA)
·07/05/13 Arterial Stiffness and Risk of Coronary Heart Disease and Stroke
·07/05/13 Prognostic Value of Aortic Pulse Wave Velocity as Index of Arterial Stiffness in the General Population
·07/05/13 Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
·07/05/13 Histone Acetyltransferase Activity of p300 Is Required for the Promotion of Left Ventricular Remodeling After Myocardial Infarction in Adult Mice In Vivo
·07/05/13 Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial Cells
·07/05/13 Administration of Hematopoietic Cytokines in the Subacute Phase After Cerebral Infarction Is Effective for Functional Recovery Facilitating Proliferation of Intrinsic Neural Stem/Progenitor Cells and
·07/05/13 Projected Valve Area at Normal Flow Rate Improves the Assessment of Stenosis Severity in Patients With Low-Flow, Low-Gradient Aortic Stenosis
·07/05/13 Tissue Factor in Cardiovascular Diseases
·07/05/13 Are Implantable Cardioverter Defibrillator Shocks a Surrogate for Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy
·07/05/13 The Jervell and Lange-Nielsen Syndrome
·07/05/13 Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age
·07/05/13 Association of a Continuous Quality Improvement Initiative With Practice and Outcome Variations of Contemporary Percutaneous Coronary Interventions
·07/05/13 Changing Incidence and Survival for Heart Failure in a Well-Defined Older Population, 1970–1974 and 1990–1994
·07/05/13 Larger Cell Size in Rabbits With Heart Failure Increases Myocardial Conduction Velocity and QRS Duration
·07/05/13 Characterization of Acute and Chronic Myocardial Infarcts by Multidetector Computed Tomography
·07/05/13 Extracellular Matrix Metalloproteinase Inducer Regulates Matrix Metalloproteinase Activity in Cardiovascular Cells
·07/05/13 Percutaneous Aortic Valve Implantation Retrograde From the Femoral Artery
·07/05/13 Percutaneous Transvenous Mitral Annuloplasty
·07/05/13 Familial Aggregation of Calcific Aortic Valve Stenosis in the Western Part of France
·07/05/13 Mitral and Aortic Annular Calcification Are Highly Associated With Systemic Calcified Atherosclerosis
·07/05/13 Peroxisome Proliferator–Activated Receptor- Activation With Pioglitazone Improves Endothelium-Dependent Dilation in Nondiabetic Patients With Major Cardiovascular Risk Factors
·07/05/13 Detection of Diverse Bacterial Signatures in Atherosclerotic Lesions of Patients With Coronary Heart Disease
·07/05/13 Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
·07/05/13 Cross-Sectional Relations of Multiple Biomarkers From Distinct Biological Pathways to Brachial Artery Endothelial Function
·07/05/13 Reduced Cardiocirculatory Complications With Unrestrictive Visiting Policy in an Intensive Care Unit
·07/05/13 Biventricular Pacing Improves the Blunted Force–Frequency Relation Present During Univentricular Pacing in Patients With Heart Failure and Conduction Delay
·07/05/13 Novel Speckle-Tracking Radial Strain From Routine Black-and-White Echocardiographic Images to Quantify Dyssynchrony and Predict Response to Cardiac Resynchronization Therapy
·07/05/13 Effect of Posterolateral Scar Tissue on Clinical and Echocardiographic Improvement After Cardiac Resynchronization Therapy
·07/05/13 Introduction of Metoprolol Increases Plasma B-Type Cardiac Natriuretic Peptides in Mild, Stable Heart Failure

1 [2] [下一页] [尾页]